桂枝茯苓胶囊联合曼月乐对子宫腺肌症患者 子宫内膜厚度及性激素水平的影响
2025-08-09李丽芳欧阳娟沈月梅黄霞康莲香郭丽芬
The Effect of Guizhi Fuling Capsules Combined with Mirena on Endometrial Thickness and Sex Hormone Levels in Patients with Adenomyosis/LILifang,OUYANG Juan,SHEN Yuemei, HUANG Xia, KANGLianxiang,GUO Lifen.//Medical Innovation of China,2025,22(16): 047-050
[Abstract]Objective:To investigate the clinical effect of Guizhi Fuling Capsules combined with Mirena in the treatment of patients with adenomyosis (AM).Method:According to the random number table method,80 patients with AMtreated inthe Ji'an Central People's Hospital from January 2O21 to January 2024 were divided into two groups,with 4O cases in each group.The control group was treated with Mirena,while the observation group was treated with GuizhiFuling Capsules on the basis of the control group.The clinical eficacy,endometrial thickness (EMT),sex hormone levels [folicle stimulating hormone (FSH),uteinizing hormone(LH),estradiol (E2)], degreeof dysmenorrhea, menstrual volume,and adverse reactions were compared between the two groups.Result: The total effective rate of the observation group was higher than that of the control group ( P lt;0.05).After treatment, the levels of EMT,FSH,and LH were lower than those of the control group,while the level of E2 was higher than that of the control group,the visual analog scale (VAS) score and the menstrual blood loss chart (PBAC) score were lower than those of the control group,the differences were statistically significant ( P lt;0.05). There was no significant difference in the incidence of adverse reactions between the two groups ( P gt;0.05).Conclusion:The treatment of AM patients with Guizhi Fuling Capsules combined with Mirena can regulate the levels of FSH,LH,and E2 ,alleviate" dysmenorrhea symptoms,reduce menstrual volume and EMT,and does not increase adverse reactions.
[Key Words]Uterine adenomyosisGuizhi Fuling CapsulesMirena Endometrial thickness Sex hormone levels
First-author'saddress:ObstetricsandGynecologyDepartment,Ji'anCentralPeople'sHospital,Jian 343100, China
doi:10.3969/j.issn.1674-4985.2025.16.012
子宫腺肌症(AM)作为妇科常见病,好发于30\~50岁女性,患者以月经量过多、痛经及子宫体积增大等为主要表现,会造成继发性贫血或不孕,会给患者带来极大的身体及心理上的痛苦[]。目前曼月乐是治疗AM的常用药物,向宫腔内置入药物,可使宫腔局部药物浓度提高,对子宫内膜增生进行抑制,减轻患者症状[2。在我国医学中,AM归属于“痛经”“寢”范畴,中医在活血消瘤、调经止痛方面具有丰富经验。桂枝茯苓胶囊属于复方中药胶囊剂,可活血、化瘀、消瘙。桂枝茯苓胶囊已在子宫肌瘤、盆腔炎等疾病中广泛应用,但目前关于将桂枝茯苓胶囊用于AM治疗中的效果相关研究较少[。鉴于此,本研究将探讨AM患者采用桂枝茯苓胶囊治疗的临床效果。现报告如下。
1资料与方法
1.1一般资料
选取2021年1月—2024年1月于吉安市中心人民医院治疗的80例AM患者。(1)纳入标准:符合文献[5]《子宫腺肌病诊治中国专家共识》中AM诊断标准;符合文献[6]《中医妇科学》中辩证寒凝血瘀证的诊断标准;子宫体积 ⩽ 孕12周;患者依从性较高,可遵医嘱治疗,积极配合各项观察指标的评估。(2)排除标准:已绝经女性;近6个月内有生育要求;妊娠期、哺乳期女性;合并心脑血管疾病;对桂枝茯苓胶囊、曼月乐过敏;合并肝、肾功能损伤;合并子宫内膜癌;合并严重器质性疾病。按随机数字表法将患者分为对照组与观察组,每组40例。患者均知情同意并签署知情同意书。本研究获吉安市中心人民医院医学伦理委员会批准。
1.2方法
对照组……
